Delivery Order SPE2DB22D1106-SPE2DB25FESE3
Award Date
6/6/25
Potential Completion Date
6/9/25
Potential Value
$29K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $9,783.88 and a completion date of May 22, 2025. The contract is not set aside and is for open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,544.73, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. This award is not a set-aside contract. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $27,974.59, is for the supply of BIMZELX 320 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,374.03, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and is a firm fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a ceiling value of $10,594.68 and an ultimate completion date of May 23, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,108.93, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract has a completion date of July 29, 2024 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $9,407.04 and an Ultimate Completion Date of April 9, 2025. The contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,588.45, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMKSN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,405.92 Firm Fixed Price delivery order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, with a period of performance through March 11, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
The federal contract award is for the delivery of BIMZELX 160 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract, worth $9,982.88, is a Firm Fixed Price Delivery Order with AmerisourceBergen Drug Corp as the prime contractor. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. The place of performance is Conshohocken, PA. This contract award is part of a larger Indefinite Delivery Contract...